SCHEMBL588762

SCHEMBL588762

CC(C)COC([O])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455053 0.80
SCHEMBL1766301 0.80
SCHEMBL25435787 0.79 TSHR (0.54)
SCHEMBL37351 0.79 TSHR (0.54)
SCHEMBL298254 0.79 TSHR (0.68)
SCHEMBL4444111 0.78 TSHR (0.33)
SCHEMBL29204143 0.78
Acetic Acid Isobutyl Ester SCHEMBL22678 0.77
SCHEMBL41548 0.77 TSHR (0.52)
Ammonia Solution, Strong SCHEMBL9998248 0.77 TSHR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 769 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020002083-A1 SUBSTITUTED HETEROCYCLIC PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2020-01-02 WO claimed
US-9630908-B2 Process for preparing lacosamide UCB PHARMA GMBH (DE) 2017-04-25 US claimed
US-20160039744-A1 Process for Preparing Lacosamide UCB PHARMA GMBH (DE) 2016-02-11 US claimed
US-9139513-B2 Process for preparing lacosamide UCB PHARMA GMBH (DE) 2015-09-22 US claimed
US-20140018577-A1 Process for Preparing Lacosamide UCB PHARMA GMBH (DE) 2014-01-16 US claimed
EP-2640691-A1 PROCESS FOR PREPARING LACOSAMIDE UCB Pharma GmbH (DE) 2013-09-25 EP claimed
EP-2487152-A1 Process for the preparation of Lacosamide including resolution of O-methyl-DL-serine UCB Pharma GmbH (DE) 2012-08-15 EP claimed
WO-2012065891-A1 PROCESS FOR PREPARING LACOSAMIDE UCB PHARMA GMBH (DE) 2012-05-24 WO claimed
US-7276524-B2 Pyridyl alkane acid amides as cytostatics and immunosuppressives ASTELLAS DEUTSCHLAND GMBH (DE) 2007-10-02 US claimed
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives ASTELLAS PHARMA GMBH (DE) 2007-09-20 US claimed
US-6444823-B1 ANTITUMOR AGENTS; IMMUNOSUPPRESSANTS; SIDE EFFECT REDUCTION KLINGE PHARMA GMBH (DE) 2002-09-03 US claimed
US-6187504-B1 PHOTOSENSITIVE BLEND CONTAINING A NAPHTHALENE SULFONIUM SULFONATE DERIVATIVE PHOTOACID GENERATOR, RESIN HAVING ALKALI INSOLUBLE GROUPS CLEAVABLE BY ACID, AN ALKALI SOLUBLE RESIN AND A SOLUBILITY CONTROL AGENT; POSITIVES, RESOLUTION JSR CORPORATION (JP) 2001-02-13 US claimed
WO-2001002351-A2 METHOD FOR PREPARING A HYDROXYLATED ARYLHYDRAZINE, INTERMEDIATE PRODUCTS AND METHOD FOR OBTAINING SAME RHODIA CHIMIE (FR) 2001-01-11 WO claimed
US-6114381-A TO CONTROL BRAIN DAMAGE ASSOCIATED WITH ANOXIA OR ISCHEMIA WHICH TYPICALLY FOLLOWS STROKE, CARDIAC ARREST OR PERINATAL ASPHYXIA; COMPOUND IS AN ANTAGONIST TO INHIBIT EXCITOTOXIC ACTIONS AT EXCITATORY AMINO ACID RECEPTOR SITES G. D. SEARLE & CO. (US) 2000-09-05 US claimed
US-5616711-A REACTING BUTENE DERIVATIVE TO AN AMIDE DERIVATIVE; USEFUL AS INTERMEDIATES FOR PRODUCING ANTIULCER DRUGS FUJIREBIO INC. (JP) 1997-04-01 US claimed
WO-1994013636-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-06-23 WO claimed
EP-0582304-A2 Methods of producing amino butene derivatives FUJIREBIO Inc. (JP) 1994-02-09 EP claimed
US-4584300-A Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor SANTEN PHARMACEUTICAL CO., LTD. (JP) 1986-04-22 US claimed
EP-0116368-A1 Benzothiazine derivatives SANTEN PHARMACEUTICAL CO., LTD. (JP) 1984-08-22 EP claimed
US-3962228-A BACTERICIDES AMERICAN HOME PRODUCTS CORPORATION (US) 1976-06-08 US claimed